AL
LGND icon

Airain Ltd’s Ligand Pharmaceuticals LGND Stock Holding History

Airain Ltd’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-8,573
Closed -$566K – 958
2017
Q1 		$566K Sell
8,573
-840
-9% -$55.3K 0.03% 461
2016
Q4 		$597K Buy
+9,413
New +$594K 0.05% 336
2016
Q1 		– Sell
-47,391
Closed -$3.21M – 950
2015
Q4 		$3.21M Buy
+47,391
New +$2.93M 0.22% 123
2015
Q2 		– Sell
-22,591
Closed -$1.09M – 982
2015
Q1 		$1.09M Sell
22,591
-30,922
-58% -$1.18M 0.07% 301
2014
Q4 		$1.78M Buy
+53,513
New +$1.74M 0.15% 182

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Airain Ltd's LGND Position: Q2 2017 in Review

Airain Ltd sold out of Ligand Pharmaceuticals (LGND) in Q2 2017, closing a stake of 8,573 shares — an estimated $566K sold.

Airain Ltd first reported a position in LGND in Q4 2014 and held it in 5 quarters. The position peaked at $3.21M in Q4 2015. 265 funds tracked by Wall St. Rank hold LGND as of Q2 2017.

  • Airain Ltd reported no remaining Ligand Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • Airain Ltd sold 8,573 Ligand Pharmaceuticals shares in Q2 2017, an estimated $566K.
  • Airain Ltd first reported a position in Ligand Pharmaceuticals in Q4 2014 and held it in 5 quarters.
  • Airain Ltd's Ligand Pharmaceuticals position peaked at $3.21M in Q4 2015.
  • 265 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.